The distributions of a gap junctional protein, connexin 32 (cx 32), and proliferating cell nuclear antigen (PCNA) were examined immunohistochemically in glutathione S-transferase placental form (GST-P)-negative foci, induced in rat liver by initiation with diethylnitrosamine (DEN, 200 mg/kg) followed by promotion with clofibrate (1% in diet) in an in vivo medium-term assay system for hepatocarcinogenesis. The results were compared to those in GST-P-positive foci induced by DEN alone. The treatment with clofibrate caused the appearance of GST-P-negative foci, increased in size as compared to GST-P-positive foci in the same liver or induced by the DEN alone. The proportion of PCNA-positive hepatocytes in GST-P-negative foci was significantly higher than in the surrounding parenchyma, indicating increased cell proliferation. The numbers of cx 32-positive spots per hepatocyte in GST-P-negative foci were clearly decreased, reaching 65.4% at week 20 and 51.8% at week 30 of values for surrounding normal hepatocytes. In GST-P-positive foci induced by DEN, only a slight decrease (80%) was observed at week 8. These findings show that a positive association between the sustained inhibition of gap junctional intercellular communication and increased cell proliferation of GST-P-negative foci in Fischer-344 male rats induced with DEN and promoted with clofibrate.
INTRODUCTION
Clofibrate, one of the groups of compounds known as peroxisome proliferators (PPs) , is a hepatocarcinogen in rats and mice (13, 16) . Because preneoplastic and neoplastic lesions in rat liver induced by PPs are negative for marker enzymes such as glutathione S-transferase (GST-P) and ~y-glutamyltranspeptidase (12) , it is rather difficult to detect the carcinogenic effects of PPs on rat liver by in vivo medium-term assay system (4, 5) . It has also been indicated that the c-myc gene product is not a useful marker for GST-P-negative foci induced by diethylnitrosamine (DEN)-clofibrate (6) . The mechanisms by which PPs lead to carcinogenesis are as yet unclear (1) .
It has been postulated that modulation of gap junctional intercellular communication (GJIC) plays an important role in carcinogenesis, because many promoting agents or activated oncogenes have been known to inhibit GJIC (7, 8, 10, 17, 19, 20) . For instance, Neveu et al (10) reported decreased expression of the major hepatocyte gap junction protein, connexin 32 (cx 32), to be a common observation in rat neoplastic lesions induced by initiation with ethylnitrosourea or DEN followed by promotion with several chemicals including PPs. Krutovskikh et al (7) also described GST-P-positive foci induced by DEN and 2-acetylaminofluorene to show marked reduction of GJIC as evidenced by a significant decrease in cx 32-positive spots.
In the present study, the distributions of cx 32 and proliferating cell nuclear antigen (PCNA) in GST-P-negative foci of rat liver induced by DEN- to those in Group 3 (DEN only). However, the sizes of GST-P-negative foci in Group 1 were clearly increased after 30 as compared to 20 wk. Table II shows proportions (%) of PCNA-positive nuclei in GST-P-positive or -negative foci and surrounding hepatocytes at weeks 20 and 30. The ratios of PCNApositive nuclei in both GST-P-positive and -negative foci were significantly elevated at weeks 20 and 30 ( Fig. 2A,   B ). Figure 3 summarizes data for the numbers of cx 32-positive spots per hepatocyte in GST-P-negative and -positive foci of Groups 1 and 3 as compared to those in surrounding hepatocytes. In the GST-P-negative foci of Group 1, numbers of cx 32-positive spots were significantly smaller than those in the surrounding hepatocytes at weeks 20 and 30 (see Fig. 4A, B) . Relative numbers of cx 32-positive spots in GST-P-negative foci were 65.8 ± 6.0% and 51.9 ± 12.5% of those in the surrounding hepatocytes at weeks 20 and 30, respectively. In the GST-P-positive foci of Group 3, numbers of cx 32-positive spots were slightly decreased to 80.1 + 9.9% at week 8 but recovered thereafter (Fig. 4C, D) .
DISCUSSION
Recent evidence (2, 3) suggests that the mechanism of tumor promotion in the liver of rodents by clofibrate may be a selection process that allows proliferation to selectively occur in so-called spontaneously initiated hepatocytes, which arise during aging.
As shown in Table I , GST-P-positive foci were induced by a single administration with DEN (Group 3), but subsequent administration of clofibrate (Group 1) decreased development of such GST-P-positive lesions while causing large GST-P-negative foci to arise. Clofibrate itself did not induce any type of focus during the 28-wk administration period (Group 2). These results suggest that clofibrate promotes the DEN-initiated cells giving rise to GST-P-negative foci.
Clofibrate enlarged the size of GST-P-negative foci at weeks 20 and 30 but showed negative effects on the size of DEN-induced GST-P-positive foci. PCNA immunohistographs showed that the cell proliferation in both GST-P-negative and -positive foci was considerably elevated as compared to that in surrounding hepatocytes. The (11) . The carcinomas are considered to develop from GST-P-positive foci through neoplastic nodules, although the majority of foci/nodules disappear during this process. The present finding that dosing with clofibrate after initiation by DEN is associated with a clear and constant reduction of GJIC within GST-P-negative foci, linked to the fact that 0.5% dietary supplementation with these agents causes hepatocellular carcinomas in 91 alo of Fischer-344 rats (14) , suggests a direct link between GST-P-negative foci (GJIC-impaired), increased mitosis, and tumor growth. The interrelationship between mitosis and altered GJIC cannot be further defined based on this study. In conclusion, the mechanism of development of GST-Pnegative foci induced by DEN-clofibrate may be considerably different from that of GST-P-positive foci.
